|
Risk factor
|
ORa
|
95% CL
|
AORb
|
95% CL
|
ARRc
|
95% CLd
|
|---|
|
Home follow-upe
|
3.27
|
2.62
|
4.09
|
2.94
|
2.33
|
3.71
|
1.21
|
1.18
|
1.24
|
|
9 months of isoniazid
|
1.50
|
1.29
|
1.74
|
0.88
|
0.73
|
1.05
|
0.97
|
0.92
|
1.01
|
|
Female
|
1.04
|
0.89
|
1.21
| | | | | | |
|
Age categories:
| | | | | | | | | |
|
Age<6
|
6.80
|
4.11
|
11.25
|
5.40
|
3.19
|
9.13
|
1.07
|
1.06
|
1.08
|
|
Age 6 to <18
|
2.71
|
2.23
|
3.30
|
2.64
|
2.10
|
3.32
|
1.11
|
1.09
|
1.12
|
|
Age 18 to <35
|
ref
| | |
ref
| | |
ref
| | |
|
Age 35 and older
|
1.21
|
1.00
|
1.45
|
1.18
|
0.96
|
1.44
|
1.05
|
0.99
|
1.10
|
|
Patient referral reason:
| | | | | | | | | |
|
Correctional/rehabilitation
|
0.23
|
0.18
|
0.31
|
0.43
|
0.32
|
0.57
|
0.59
|
0.47
|
0.71
|
|
TST converters/TB contactsf
|
1.30
|
0.99
|
1.70
|
1.23
|
0.93
|
1.63
|
1.04
|
0.98
|
1.10
|
|
Postpartum women
|
0.44
|
0.33
|
0.59
|
0.64
|
0.47
|
0.87
|
0.80
|
0.67
|
0.94
|
|
TST+g from screening
|
ref
| | |
ref
| | |
ref
| | |
|
Place of birth:
| | | | | | | | | |
|
Africa
|
1.34
|
0.72
|
2.50
|
1.29
|
0.67
|
2.49
|
1.07
|
0.87
|
1.21
|
|
Asia
|
1.60
|
1.21
|
2.13
|
1.62
|
1.18
|
2.22
|
1.09
|
1.03
|
1.14
|
|
Europe
|
1.83
|
1.03
|
3.25
|
1.93
|
1.06
|
3.53
|
1.10
|
1.01
|
1.16
|
|
Latin America
|
1.17
|
0.91
|
1.52
|
1.25
|
0.93
|
1.67
|
1.06
|
0.98
|
1.13
|
|
Unknown
|
0.95
|
0.62
|
1.45
|
1.06
|
0.67
|
1.68
|
1.02
|
0.87
|
1.14
|
|
USA
|
ref
| | |
ref
| | |
ref
| | |
-
aAnalysis by logistic regression.
-
bAdjusted OR. Multivariate model included: type of follow-up, regimen, age (categories), patient referral reason, and place of birth.
-
cAdjusted Risk Ratio, calculated from adjusted OR.
-
dAdjusted Risk Ratio 95% confidence limits, calculated from adjusted OR.
-
eHome-based follow-up with public health nurses and community health workers.
-
fTuberculin skin test converters or contacts of cases with active tuberculosis.
-
gTST+: Tuberculin skin test positive.
